Cell-borne 2D nanomaterials for efficient cancer targeting and photothermal therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28426974.
- Also identified by DOI 10.1016/j.biomaterials.2017.04.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two of the challenges for clinical implementation of nano-therapeutic strategies are optimization of tumor targeting and clearance of the nanoagents in vivo. Herein, a cell-mediated therapy by transporting 2D Bi<sub>2</sub>Se<sub>3</sub> nanosheets within macrophage vehicles is described. The Bi<sub>2</sub>Se<sub>3</sub> nanosheets with excellent near-infrared photothermal performance exhibit high macrophage uptake and negligible cytotoxicity thus facilitating the fabrication of Bi<sub>2</sub>Se<sub>3</sub>-laden-macrophages. Compared with bare Bi<sub>2</sub>Se<sub>3</sub>, the Bi<sub>2</sub>Se<sub>3</sub>-laden-macrophages after intravenous injection show prolonged blood circulation and can overcome the hypoxia-associated drug delivery barrier to target the tumor efficiently and dramatically enhance the efficiency of photothermal cancer therapy. The Bi<sub>2</sub>Se<sub>3</sub>-laden-macrophages possess good biocompatibility as demonstrated by the biochemical and histological analyses and furthermore, most of the materials are excreted from the body within 25 days. Our findings reveal a desirable system for highly efficient near-infrared photothermal cancer therapy.
Medical subject headings
- Nanostructures
- Phototherapy